Albert Labs International Corp. (ABRT.CN) Research

Albert Labs International Corp. is a pharmaceutical research and development company dedicated to addressing urgent and underserved patient needs, particularly in critical mental health. The firm specializes in creating psilocybin-assisted therapies aimed at improving conditions such as anxiety, depression, and the psychological distress linked to cancer. This enterprise operates out of Burnaby, Canada.

Market snapshot

Symbol
ABRT.CN
Price
$0.01
Day change
0.00%
Market cap
$372.1K
P/E ratio
-0.04x
52-week range
0.005-0.035
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Aquarius Surgical Technologies Inc. (ASTI.CN)
  • Bioasis Technologies Inc. (BTI.V)
  • ChitogenX Inc. (CHGX.CN)
  • Biocure Technology Inc. (CURE.CN)
  • Restart Life Sciences Corp. (HEAL.CN)
  • Jack Nathan Medical Corp. (JNH.V)
  • Nirvana Life Sciences Inc. (NIRV.CN)
  • NanoSphere Health Sciences Inc. (NSHS.CN)

Open Albert Labs International Corp. (ABRT.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.